Blood Coagulation Disorders  >>  Nuwiq (simoctocog alfa)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nuwiq (simoctocog alfa) / Octapharma
NuPreviq, NCT01863758 / 2013-001556-35: Assess the Safety and Efficacy of Individually Tailored Prophylaxis With Human-cl rhFVIII in Patients With Severe Haemophilia A

Checkmark Efficacy and immunogenicity data in patients with hemophilia A at EAHAD 2020
Feb 2020 - Feb 2020: Efficacy and immunogenicity data in patients with hemophilia A at EAHAD 2020
Checkmark Safety and efficacy data in patients with severe hemophilia A
May 2018 - May 2018: Safety and efficacy data in patients with severe hemophilia A
Checkmark
More
Completed
3b
66
Europe
Human-cl rhFVIII
Octapharma
Severe Haemophilia A
01/15
01/15
NCT01125813 / 2009-011055-43: Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A

Checkmark
Sep 2015 - Sep 2015: 
Checkmark P3 Data
Nov 2012 - Nov 2012: P3 Data
Completed
3
32
Europe
recombinant Factor VIII, human-cl rhFVIII
Octapharma
Severe Hemophilia A
01/12
01/12

Download Options